About Be Well

What is Semaglutide:

Semaglutide (Ozempic®) is an anti-diabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management. It is a peptide similar to the hormone glucagon-like peptide-1. 

Weight Management:

Semaglutide has also been approved under different brand names for weight management in individuals with obesity or overweight conditions. Clinical trials have demonstrated its effectiveness in promoting significant weight loss when used alongside a reduced-calorie diet and increased physical activity.

Key Points:

• Administration: Weekly injections.
• Brand Names: Semaglutide is marketed under different brand names, such as Ozempic (for diabetes) and Wegovy (for weight management).
• Weight Loss Results: In clinical studies, 80% of users in 12 months achieved success, individuals can see benefits within 4 weeks. 
• Compounded with Pyridoxine/B6 which helps fight side effects such as nausea and helps better metabolize fats, proteins, and carbohydrates. 

Sublingual option is compounded with Cyanocobalamin/B12. 

What is Tirzepatide:

Tirzepatide (Mounjero®, Zepbound®) is a medication used primarily to manage type 2 diabetes. It's a synthetic peptide that mimics the action of two hormones, GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory peptide), which are involved in regulating blood sugar levels.

Weight Management:

Tirzepatide is marketed under the brand name Mounjaro. The drug works by mimicking the action of two hormones—GLP-1 and GIP—that help regulate blood sugar levels and appetite. For weight loss, this means it can help reduce hunger and increase feelings of fullness, leading to decreased caloric intake and subsequent weight loss.

Key Points:

• Dual Action: Tirzepatide is a dual GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory peptide) receptor agonist, meaning it mimics the actions of both hormones involved in blood sugar regulation and appetite control.
• Compounded with Cyanocobalamin/B12 which helps increase metabolism and energy levels. 
• Primary Use: It is primarily used to manage type 2 diabetes, helping to improve blood sugar control when combined with diet and exercise.
• Weight Loss: Tirzepatide has shown significant potential for weight loss, with clinical trials indicating that it can lead to substantial reductions in body weight. This effect is attributed to its impact on appetite and satiety.
• Administration: Daily sublingual oral dosing or weekly injections.
• Efficacy: Clinical trials have demonstrated that tirzepatide effectively lowers HbA1c (a marker of long-term blood glucose levels) and contributes to weight loss. Weight loss outcomes can vary but have been substantial in many studies.

What is Qsymia:

Qsymia is a prescription medication used for weight loss in individuals who are overweight or obese. It is a combination of two drugs: phentermine and topiramate.

• Phentermine is a sympathomimetic drug that acts as an appetite suppressant, helping to reduce hunger.
• Topiramate is an anticonvulsant medication that has weight loss effects, possibly by increasing feelings of fullness and reducing food cravings.

Weight Management:

Qsymia works by helping to reduce hunger and promote feelings of satiety, which can lead to reduced calorie intake and weight loss. It is typically used alongside a healthy diet and exercise program.

Key Points:

• Qsymia combines phentermine, an appetite suppressant, which helps reduce hunger and cravings. This can make it easier for individuals to stick to a calorie-controlled diet.
• Helps improve or even reverse certain comorbidities (other health problems) related to obesity, including:
  • Type 2 diabetes
  • High blood pressure
  • High cholesterol levels
  • Sleep apnea
• Better long term weight management
• Better long term weight managment